Total Funding
90
61
Total FundingPost-IPO Equity raised
Growth Score
15 pts
Heat Score
-14 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
158761
CSL develops innovative biotherapies and influenza vaccines that save lives, and help people with life-threatening medical conditions.
John Shine: Chairman- Gordon Naylor: CEO & Managing Director
Hongkong Telecom
About the Company
CSL Limited is a public company which is a parent company of the CSL Group. CSL business activities operate in the Human Health, JRH Biosciences, Animal Health and ZLB Plasma Services operations.
CSL limited develops, manufactures and markets pharmaceutical products of biological origin. The company' s business is:
- Health care;
-
Life-saving products derived from human plasma;
- Pharmaceuticals and diagnostics essential to health;
- Cell culture reagents for the pharmaceutical industry;
- Veterinary vaccines and diagnostics to protect livestock and companion animals.
